COGT
Cogent Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$34.67
−0.80%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-70.8%
Return on equity
-45.2%
Return on assets
-50.1%
Return on invested capital
0.00x
Asset turnover
-$307.5M
Cash from operations
$4.57
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026